I help healthtech teams and investors understand how infection, AMR and pathogen genomics work in health and beyond
25 years in the NHS with 13 years as a consultant microbiologist, followed by time at UKHSA and five years as Chief Medical Officer of a healthtech and bioinformatics startup. I help founders, product teams and investors understand infection, antimicrobial resistance and pathogen genomics, from hospital labs and infection prevention teams to public health surveillance and the wider One Health landscape. I bring an insider’s view of how these systems actually work, who makes the decisions, and where new technologies can genuinely add value, so you can test your assumptions, sharpen your use case and avoid costly missteps.
Book a private video call to get personalized advice and guidance.
A focused conversation on one specific question about infection, AMR or pathogen genomics. Ideal if you’re exploring an idea, checking an assumption or preparing for an important meeting. We can cover topics such as: How hospital labs, infection prevention teams or public health agencies would see your product or idea. Whether the clinical or public health problem you’re solving is real and a priority Please include a short summary when you book so we can make the most of the time
An in-depth, independent view for investors assessing infection, AMR, diagnostics or genomics companies. We’ll test the clinical need, how NHS and public health teams would really use the product, adoption barriers, competitors and key risks. Share the company overview and your main questions when booking so we can focus on what matters. Advisory insight only, not formal regulatory, legal or financial advice.
Book a private video call to get personalized advice and guidance.
A focused conversation on one specific question about infection, AMR or pathogen genomics. Ideal if you’re exploring an idea, checking an assumption or preparing for an important meeting. We can cover topics such as: How hospital labs, infection prevention teams or public health agencies would see your product or idea. Whether the clinical or public health problem you’re solving is real and a priority Please include a short summary when you book so we can make the most of the time
An in-depth, independent view for investors assessing infection, AMR, diagnostics or genomics companies. We’ll test the clinical need, how NHS and public health teams would really use the product, adoption barriers, competitors and key risks. Share the company overview and your main questions when booking so we can focus on what matters. Advisory insight only, not formal regulatory, legal or financial advice.